RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 25 - per page Next page
Order by
APR has successfully designed and completed the development of Veloderm, an innovative Biotechnology device for wound healing and licensed to Medestea the exclusive worldwide marketing rights More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
York, UK, 15 Jan 2006 - Pharmaceutical research and development in China is being constantly accelerated by successful clinical trials, a growing number of established R&D specialist companies and scientific technical expertise More
CRT and The Beatson Institute Announce Research Collaboration in Tumour Imaging with AstraZeneca More
Abiogen Licenses RFB4 Antibody from Cancer Research Technology More
STALLERGENES SA and CMC Biopharmaceuticals A/S announce today that they have entered into an agreement for development and supply of recombinant Bet v 1 (rBet v 1) purified bulk More
Cancer Research Technology Grants Waypharm S.A.S Option to Novel Platinum Agents More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
Cancer Research Technology Announce Milestone following Initiation of Stimuvax® Phase 3 Trial in Non Small Cell Lung Cancer More
CRT Establishes Crystallography Facility at Birkbeck, University of London More
Displaying 1..10 of 25 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us